A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)

NCT01021527 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

OTHER: Comparator: Treatment A
DRUG: Comparator: Treatment B
DRUG: Comparator: Treatment C
PROCEDURE: Comparator: graded glucose infusion

Sponsor

Merck Sharp & Dohme LLC